Second line treatment (2 LT) in small cell lung cancer (SC).
In spite of the possibility to obtain a high percentage of objective response, the overall median survival for small cell lung cancer patients did not improve substantially in the last 10 years. Second line treatment fails to provide definitive care, however, some practical guide lines can be planned to face the problem of how and when to treat relapsed small cell lung cancer patients.
Clerici
M
M
Divisione Oncologia Medica, Ospedale S. Carlo Borromeo, Milano, Italy.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D018288:Carcinoma, Small Cell / Q000188:drug therapy*; D017322:Clinical Trials, Phase II as Topic; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents